Abstract
In recent years, rapamycin has been used as an immunosuppressive agent in clinical practice. Rapamycin has the effect of accelerating lipid metabolism in the test, but it has the adverse reaction of hyperlipidemia at the same time. In view of this double-side conclusion, this article mainly analyzes the following aspects: direct inhibition of mTOR pathway, reduce expression of peroxisome proliferator-activated receptor γ, inhibition of leptin secretion, down-regulation of cholesterol-regulating element binding protein and excitation cell autophagy. Based on current research at home and abroad, it suggested that the the effects of dose-response effects of rapamycin and the exact mechanism of interaction between PI3K/PKB/mTOR signaling pathways and other cytokines can be a further research direction, so that the relationship between rapamycin and blood lipid metabolism can be learn more about in a quantify way. Key words: Kidney transplantation; Lipid metabolism disorders; Cytokines; Autophagy; Rapamycin
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
